4//SEC Filing
Lillie James Woodruff 4
Accession 0001209191-18-062124
CIK 0001544227other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:46 PM ET
Size
5.8 KB
Accession
0001209191-18-062124
Insider Transaction Report
Form 4
Lillie James Woodruff
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-10+8,333→ 8,333 totalExercise: $13.98Exp: 2028-05-10→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
- [F2]The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).
Documents
Issuer
Millendo Therapeutics, Inc.
CIK 0001544227
Entity typeother
Related Parties
1- filerCIK 0001728746
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 7:46 PM ET
- Size
- 5.8 KB